DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D. et al.
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med 2019;
380: 1116-27
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.